Janney Capital Management LLC Has $12.66 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Janney Capital Management LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.7% in the 4th quarter, HoldingsChannel reports. The fund owned 25,032 shares of the healthcare conglomerate’s stock after selling 955 shares during the period. Janney Capital Management LLC’s holdings in UnitedHealth Group were worth $12,663,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of UNH. Kathleen S. Wright Associates Inc. purchased a new position in shares of UnitedHealth Group during the third quarter valued at approximately $27,000. Global Wealth Strategies & Associates boosted its holdings in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the last quarter. West Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the third quarter valued at about $32,000. Quarry LP grew its position in UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 37 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $37,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday. Oppenheimer boosted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. TD Cowen raised their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Finally, UBS Group reduced their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Stock Performance

NYSE UNH opened at $519.08 on Thursday. The company’s 50 day simple moving average is $545.26 and its two-hundred day simple moving average is $564.10. The stock has a market capitalization of $477.70 billion, a PE ratio of 33.49, a P/E/G ratio of 1.42 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the business earned $5.83 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.75 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.